1-3 of 3
Rachel Waters
Close
Sort by
Journal Articles

Mitoxantrone, Not Idarubicin, Significantly Improves the Outcome of Children with Relapsed ALL – Result of the International, Randomised ALLR3 Study.

Catriona Parker, Rachel Waters, Carly Leighton, Jeremy Hancock, Anthony Moorman, Mary Morgan, Philip Ancliff, Nicholas Goulden, Rosemary Sutton, Tamas Revesz, Philip Darbyshire, Sharon Love, Vaskar Saha
Journal: Blood
Blood (2009) 114 (22): 3390.
https://doi.org/10.1182/blood.V114.22.3390.3390
Published: 2009
Journal Articles

Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation

Brief Report
Derville O'Shea, Ciarán O'Riain, Manu Gupta, Rachel Waters, Youwen Yang, David Wrench, John Gribben, Andreas Rosenwald, German Ott, Lisa M. Rimsza, Harald Holte, Jean-Baptiste Cazier, Nathalie A. Johnson, Elias Campo, Wing C. Chan, Randy D. Gascoyne, Bryan D. Young, Louis M. Staudt, T. Andrew Lister, Jude Fitzgibbon
Journal: Blood
Blood (2009) 113 (10): 2298–2301.
https://doi.org/10.1182/blood-2008-08-174953
Published: 2009
Includes: Supplemental data
Journal Articles

The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival

Brief Report
Derville O'Shea, Ciarán O'Riain, Claire Taylor, Rachel Waters, Emanuela Carlotti, Finlay MacDougall, John Gribben, Andreas Rosenwald, German Ott, Lisa M. Rimsza, Erlend B. Smeland, Nathalie Johnson, Elias Campo, Timothy C. Greiner, Wing C. Chan, Randy D. Gascoyne, George Wright, Louis M. Staudt, T. Andrew Lister, Jude Fitzgibbon
Journal: Blood
Blood (2008) 112 (8): 3126–3129.
https://doi.org/10.1182/blood-2008-05-154013
Published: 2008
Includes: Supplemental data